Literature DB >> 2004824

Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Z D Cui1, D Tristram, L J LaScolea, T Kwiatkowski, S Kopti, P L Ogra.   

Abstract

Groups of BALB/c mice were orally immunized with Chlamydia trachomatis serovar L2/434/Bu in order to characterize the nature and kinetics of the chlamydial antibody response in the cervix and other mucosal sites. These animals were subsequently challenged intravaginally to determine whether oral immunization offers protection against chlamydial antigen shedding in the genital tract. Following oral immunization, immunoglobulin A antibody activity was detected in the genital tract as well as other mucosal sites. Subsequent intravaginal challenges exhibited booster effects on preexisting antibody activity in the genital tract. Significant protection against challenge infection in the genital tract was observed by oral immunization. This was indicated by the absence of any chlamydial antigen shedding in cervical secretions. On the other hand, passively administered chlamydial-specific serum immunoglobulin G antibody did not significantly influence the course of cervical shedding of the organism and did not confer any protection against a subsequent intravaginal challenge. It is concluded that prior oral immunization can induce a secretory antibody response in the genital tract and provide protection against subsequent infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004824      PMCID: PMC257864          DOI: 10.1128/iai.59.4.1465-1469.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Isolation of Chlamydia trachomatis from the male urethra.

Authors:  M D Alani; S Darougar; D C Burns; R N Thin; H Dunn
Journal:  Br J Vener Dis       Date:  1977-04

2.  Immunoprophylaxis of Chlamydia trachomatis lymphogranuloma venereum pneumonitis in mice by oral immunization.

Authors:  Z D Cui; L J LaScolea; J Fisher; P L Ogra
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 3.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjuctivae by eye secretions from humans with trachoma.

Authors:  R L Nichols; R E Oertley; E C Fraser; A B MacDonald; D E McComb
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

5.  Animal model studies of genital chlamydial infections. Immunity to re-infection with guinea-pig inclusion conjunctivitis agent in the urethra and eye of male guinea-pigs.

Authors:  L V Howard; M P O'Leary; R L Nichols
Journal:  Br J Vener Dis       Date:  1976-08

6.  Chlamydia trachomatis infant pneumonitis: comparison with matched controls and other infant pneumonitis.

Authors:  H R Harrison; M G English; C K Lee; E R Alexander
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

7.  Immunity to vaginal reinfection in female guinea pigs infected sexually with Chlamydia of guinea pig inclusion conjunctivitis.

Authors:  H C Lamont; D Z Semine; C Leveille; R L Nichols
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs.

Authors:  R L Nichols; E S Murray; P E Nisson
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

9.  Prospective study of chlamydial infection in neonates.

Authors:  J Schachter; M Grossman; J Holt; R Sweet; E Goodner; J Mills
Journal:  Lancet       Date:  1979-08-25       Impact factor: 79.321

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  24 in total

1.  Chlamydial colonization of multiple mucosae following infection by any mucosal route.

Authors:  L L Perry; S Hughes
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

Review 3.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.

Authors:  N Mielcarek; I Nordström; F D Menozzi; C Locht; J Holmgren
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Secretory immune responses to Mycoplasma pulmonis.

Authors:  M J Steffen; J L Ebersole
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

6.  Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans.

Authors:  A Rudin; E L Johansson; C Bergquist; J Holmgren
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

7.  Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.

Authors:  K Eriksson; M Quiding-Järbrink; J Osek; A Möller; S Björk; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.

Authors:  M Johansson; K Schön; M Ward; N Lycke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

9.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Tonsillar application of AT-2 SIV affords partial protection against rectal challenge with SIVmac239.

Authors:  Panagiotis Vagenas; Vennansha G Williams; Michael Piatak; Julian W Bess; Jeffrey D Lifson; James L Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.